Antibody Sequencing
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring antibody sequencing services, with solicitation release estimated for January 1, 2027, and award targeted for April 1, 2027. This is a new requirement classified as priority 3.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Center for Biologics Evaluation and Research Acquisitions mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
Antibody Sequencingnew service requirement, priority 3
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast